Selected article for: "co infection and cytokine storm"
Author: Niles, Marc A.; Gogesch, Patricia; Kronhart, Stefanie; Ortega Iannazzo, Samira; Kochs, Georg; Waibler, Zoe; Anzaghe, Martina
Title: Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection
  • Cord-id: osz0g2th
  • Document date: 2021_5_26
    • ID: osz0g2th
    Snippet: The exact role of innate immune cells upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and their contribution to the formation of the corona virus-induced disease (COVID)-19 associated cytokine storm is not yet fully understood. We show that human in vitro differentiated myeloid dendritic cells (mDC) as well as M1 and M2 macrophages are susceptible to infection with SARS-CoV-2 but are not productively infected. Furthermore, infected mDC, M1-, and M2 macrophages sh
    Document: The exact role of innate immune cells upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and their contribution to the formation of the corona virus-induced disease (COVID)-19 associated cytokine storm is not yet fully understood. We show that human in vitro differentiated myeloid dendritic cells (mDC) as well as M1 and M2 macrophages are susceptible to infection with SARS-CoV-2 but are not productively infected. Furthermore, infected mDC, M1-, and M2 macrophages show only slight changes in their activation status. Surprisingly, none of the infected innate immune cells produced the pro-inflammatory cytokines interleukin (IL)−6, tumor necrosis factor (TNF)-α, or interferon (IFN)−α. Moreover, even in co-infection experiments using different stimuli, as well as non-influenza (non-flu) or influenza A (flu) viruses, only very minor IL-6 production was induced. In summary, we conclude that mDC and macrophages are unlikely the source of the first wave of cytokines upon infection with SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • activation marker and lung damage: 1
    • activation marker and lymph node: 1
    • activation status and lps stimulation: 1
    • activation status and lung damage: 1
    • activation status and lymph node: 1
    • activation status and lymph spleen: 1
    • acute patient and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute patient and lung macrophage: 1, 2
    • acute patient and lymph node: 1, 2, 3, 4, 5, 6, 7, 8
    • acute patient and lymph spleen: 1, 2, 3, 4
    • acute patient and lymph spleen node: 1, 2
    • lps stimulation and lung resident: 1
    • lung damage and lymph node: 1, 2
    • lung damage and lymph spleen: 1, 2
    • lung damage and m1 macrophage: 1, 2, 3, 4